Corporate Culture Has No Place in Academia
By Olof Hallonsten,
Nature News
| 10. 03. 2016
The eyes of the world are on the Karolinska Institute in Stockholm this week for the announcement of the Nobel prize in medicine, but an ugly medical scandal lurks in the background. The case of Paolo Macchiarini involved the deaths of multiple patients and several instances of research fraud, and has exposed the misdeeds of a single professor. But it also demonstrates the risks of academic capitalism: a global trend that turns universities into businesses. In this respect, the story has wider lessons for us all.
As academic capitalism spreads, universities abandon traditional meritocratic and collegial governance to hunt money, prestige and a stronger brand. Here in Sweden, this shift has been especially profound: since the 1980s, the university system has been deregulated, and its core principles gradually replaced by management practices from the corporate world. Government research policy over the past decade has further pushed universities to centralize their strategic management and increase their international visibility. Major strategic funding programmes included one to recruit international star scientists.
An investigation into the Macchiarini scandal, led by a former president of...
Related Articles
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
By Emily Mullin, Wired | 03.23.2026
As the Trump administration phases out the use of animal experimentation across the federal government, a biotech startup has a bold idea for an alternative to animal testing: nonsentient “organ sacks.”
Bay Area-based R3 Bio has been quietly pitching the...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...